Tirzepatide already demonstrated the power of adding GIP agonism to GLP-1, and retatrutide builds on that foundation
Robert Kushner: I haven't seen that paper, but what I can say which I thought you were getting to is that when we look at the categorical weight loss in all these trials, so some people lose 5%, 10%, 20%, 25% over the course of the trial, if you then stop the medication, the individuals who lost the greatest amount of body weight actually are the ones that regain it the quickest
In fact, many adults are unable to absorb B-12 into their body at all
If you have a good amount of body fat at the site, 90 degrees is standard
The apparent clearance (CL/F) of galcanezumab-gnlm was 0.008 L/h and the elimination half-life of galcanezumab was approximately 27 days
& Yoo, D